Loss of sex-determining region Y-box 2 (Sox2) captures embryonic stem cells in a primed pluripotent state
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Min Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical…. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Pluripotent Stem Cells, Mouse Embryonic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Wannan Medical College.
Abstract (Originalsprache)
Two main pluripotent cell lines can be established from the preimplantation and postimplantation mouse embryo as naïve embryonic stem cells (ESCs) and primed epiblast stem cells (EpiSCs), respectively. Although the two pluripotent states are interconvertible, the molecular mechanism controlling the transition between naïve and primed pluripotency remains to be fully elucidated. Here, by performing a CRISPR-based loss-of-function screen in ESCs, we identify Sox2 involved in the repression of lineage-specification marker brachyury (T). Upon Sox2 ablation in ESCs, two populations of cells mutually exclusive for CDX2 (trophectoderm marker) and T expression can be observed. T-positive cells display features resembling the salient characteristics of EpiSCs including molecular and functional properties. By using genetic ablation approach, we show that acquisition and maintenance of primed pluripotency in Sox2 null T-positive cells heavily depend on fibroblast growth factor (Fgf) and Nodal, which is produced in an autocrine manner in these cells. We further demonstrate that Sox3 compensates for the absence of Sox2 in maintaining the primed state of Sox2-null pluripotent cells. Establishment of Sox2-deficient pluripotent cells will enable the elucidation of the mechanisms controlling the transition of cells between different states of pluripotency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.
- School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- The Translational Research Institute for Neurological Disorders, Department of Neurosurgery, The First Affiliated Hospital (Yijishan Hospital) of Wannan Medical College, Wannan Medical College, Wuhu, China. Electronic a…
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China; Jiangsu Key Laboratory…
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Wannan Medical College
Zitieren
APA
Qi, M., Wang, B., Liao, H., Xu, Y., Dong, L., Xu, L., Xia, Y., Jiang, X., Ling, S., & Qin, J. (2025). Loss of sex-determining region Y-box 2 (Sox2) captures embryonic stem cells in a primed pluripotent state. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108501
Vancouver
Qi M, Wang B, Liao H, Xu Y, Dong L, Xu L, et al. Loss of sex-determining region Y-box 2 (Sox2) captures embryonic stem cells in a primed pluripotent state. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108501
BibTeX
@article{Qi2025,
author = {Qi, Min and Wang, Bowen and Liao, Huaqi and Xu, Yuzhuo and Dong, Lixia and Xu, Lijun and Xia, Yin and Jiang, Xiaochun and Ling, Shizhang and Qin, Jinzhong},
title = {Loss of sex-determining region Y-box 2 (Sox2) captures embryonic stem cells in a primed pluripotent state},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108501}
}
EUVIMED